Cobitolimod is under investigation in clinical trial NCT03178669 (The Efficacy of Cobitolimod in Patients With Moderate to Severe Active Ulcerative Colitis).
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.